Management of Chronic Graft-versus-Host Disease, Spanish cGVHD Panel,
Bacterial Autofluorescence Imaging for Hard-to-Heal Wounds, APWCA,
Negative-Pressure Therapy for Vascular Groin Incisions, PROPER-VASC,
Advanced Mycosis Fungoides and Sézary Syndrome, EHA/EORTC/ISCL/EBMT,
Superficial Radiation Therapy Using Low-Energy Kilovoltage X-Rays, AAPM,
Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma, DDG/ADO,
Management of Fungal Nail Infection, BAD,
Management of Hidradenitis Suppurativa, AAD/HSF,
Optimal Use and Documentation of Cellular, Acellular and Matrix-Like Products, International Expert Panel,
Preventing Acute Radiation Dermatitis With Barrier-Forming Topical Agents, MASCC,
Low-Dose Oral Minoxidil for Paediatric Hair Disorders, Paediatric LDOM Consensus Group,
WHO Classification of Genetic Tumour Syndromes, WHO/IARC,
Cutaneous Toxicities of T-Cell-Redirecting Therapies in Multiple Myeloma, EADV,
Drug Hypersensitivity Skin Testing: Methods and Non-Irritative Concentrations, EAACI,
Levodopa and Melanoma in Parkinson's Disease, MDS,
The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus, BSR (UKKA-endorsed),
Bacterial Skin and Soft Tissue Infections in Children, CPS,
Quality-of-Life Measurement in Hidradenitis Suppurativa: 2026 Update, EADV,
Invasive Cutaneous Squamous Cell Carcinoma: Diagnosis and Prevention, EADO/EDF/ESTRO/UEMS-DV/EORTC,
Treatment of Invasive Cutaneous Squamous Cell Carcinoma, EADO/EDF/ESTRO/UEMS-DV/EORTC,
Topical Corticosteroids for Acute Radiation Dermatitis, MASCC,
Management of Atopic Dermatitis in Children and Adolescents, AAD,
Uveal Melanoma, ESMO/EURACAN,
Management of Classic Lichen Planopilaris, EADV,
Treatment of Acne: 2026 EuroGuiDerm Update, EuroGuiDerm,
Management of Nodular Prurigo, BAD,
Autoimmune Blistering Diseases in Children and Adolescents, EADV,
Non-Biological and RNA-Based Therapies for Chronic Inflammatory Diseases, EAACI,
Definition, Classification, Diagnosis and Management of Urticaria, GA²LEN/EuroGuiDerm/APAAACI/AAD/BSACI/GAAACI,
Treatment of Systemic Lupus Erythematosus, ACR,
Difficult-to-Manage and Treatment-Refractory Psoriatic Arthritis, EULAR,
Management of Behçet’s Disease — 2025 Living Update, BAD/BSR,
Management of Psoriatic Arthritis, APLAR,
Treatment of Systemic Sclerosis, EULAR,
Management of Systemic Sclerosis, BSR,
Management of Behçet’s Disease — 2024 Living Guideline, BAD/BSR,
Pharmacological Management of Psoriatic Arthritis, EULAR,
